Related Experiment Video
Updated: Jul 16, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Papillary muscle repositioning in mitral valve replacement in patients with left ventricular dysfunction
Mohammad Ali Yousefnia1, Mohammad Hossein Mandegar, Farideh Roshanali
1Day General Hospital, Tehran, Iran.
The Annals of Thoracic Surgery
|February 20, 2007
Summary
Papillary muscle repositioning during mitral valve replacement improves left ventricular function and shape more effectively than preserving chordal structures. This technique offers significant early and late benefits for patients with left ventricular dysfunction.
Area of Science:
- Cardiovascular Surgery
- Cardiac Mechanics
- Valvular Heart Disease
Background:
- Left ventricular dysfunction is a significant concern in patients undergoing mitral valve replacement.
- Assessing novel surgical techniques for improving outcomes in these patients is crucial.
Purpose of the Study:
- To evaluate the feasibility and impact of papillary muscle repositioning (PMR) versus complete chordal-sparing (CMVR) during mitral valve replacement.
- To determine the effects of PMR on left ventricular (LV) remodeling and function.
Main Methods:
- A prospective randomized study of 100 patients with LV ejection fraction <40% undergoing mitral valve replacement.
- Patients were assigned to either PMR (n=50) or CMVR (n=50).
- Echocardiography assessed LV dimensions, shape, and function preoperatively, at discharge, and at 2 years.
Main Results:
- Both groups showed initial decreases in LV end-diastolic and -systolic volumes.
- The PMR group demonstrated more significant and sustained reductions in LV volumes and sphericity index.
- Ejection fraction significantly increased in the PMR group, unlike the CMVR group.
Conclusions:
- Papillary muscle repositioning leads to more favorable left ventricular remodeling post-mitral valve replacement compared to complete chordal retention.
- PMR offers significant early and late clinical advantages, including reduced LV chamber volume and improved systolic performance.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...